Page last updated: 2024-08-16

terfenadine and mdv 3100

terfenadine has been researched along with mdv 3100 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berman, JN; Collins, CC; Dellaire, G; Holly, A; MacDonald, M; Melong, N; Steele, S; Zoubeidi, A	1

Other Studies

1 other study(ies) available for terfenadine and mdv 3100

Article	Year
Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia. Scientific reports, 2017, 10-31, Volume: 7, Issue:1 Topics: Animals; Antineoplastic Agents; Benzamides; Bradycardia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Embryo, Nonmammalian; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Receptors, Androgen; Terfenadine; Testosterone; Xenograft Model Antitumor Assays; Zebrafish	2017

Article

Year

Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia.

Scientific reports, 2017, 10-31, Volume: 7, Issue:1

Topics: Animals; Antineoplastic Agents; Benzamides; Bradycardia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Embryo, Nonmammalian; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Receptors, Androgen; Terfenadine; Testosterone; Xenograft Model Antitumor Assays; Zebrafish

2017